Skip to main content

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Teva Pharmaceutical Industries

(

TEVA

) pushed the Health Care sector lower today making it today's featured Health Care laggard. The sector as a whole closed the day up 0.1%. By the end of trading, Teva Pharmaceutical Industries fell $0.48 (-1.2%) to $39.36 on light volume. Throughout the day, 4,105,499 shares of Teva Pharmaceutical Industries exchanged hands as compared to its average daily volume of 6,332,100 shares. The stock ranged in price between $39.20-$39.82 after having opened the day at $39.70 as compared to the previous trading day's close of $39.84. Other companies within the Health Care sector that declined today were:

CEL-SCI Corporation

(

CVM

), down 20.0%,

Neogen Corporation

(

NEOG

), down 8.9%,

Esperion Therapeutics

(

ESPR

TheStreet Recommends

), down 8.7% and

Relypsa

(

RLYP

), down 7.1%.

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes pharmaceutical products worldwide. Teva Pharmaceutical Industries has a market cap of $33.7 billion and is part of the drugs industry. The company has a P/E ratio of 17.7, above the S&P 500 P/E ratio of 17.7. The company has a P/E ratio of 17.7, equal to the S&P 500 P/E ratio of 17.7. Shares are up 6.7% year to date as of the close of trading on Wednesday. Currently there are 5 analysts that rate Teva Pharmaceutical Industries a buy, 3 analysts rate it a sell, and 11 rate it a hold.

TheStreet Ratings rates

Teva Pharmaceutical Industries

as a

hold

. The company's strengths can be seen in multiple areas, such as its increase in net income, revenue growth and largely solid financial position with reasonable debt levels by most measures. However, as a counter to these strengths, we also find weaknesses including disappointing return on equity, weak operating cash flow and relatively poor performance when compared with the S&P 500 during the past year.

On the positive front,

Alimera

(

ALIM

), up 62.8%,

pSivida

(

PSDV

), up 35.0%,

Oxygen Biotherapeutics

(

OXBT

), up 18.5% and

American Shared Hospital Services

(

AMS

), up 12.3% , were all gainers within the health care sector with

Allergan

(

AGN

) being today's featured health care sector leader.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider

Health Care Select Sector SPDR

(

XLV

) while those bearish on the health care sector could consider

ProShares Ultra Short Health Care

(

RXD

).

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.